Related Experiment Video

Updated: Jul 29, 2026

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo
07:33

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo

Published on: September 28, 2022

Immunomodulators and delivery systems for vaccination by mucosal routes

E J Ryan1, L M Daly, K H Mills

  • 1Institute of Immunology, National University of Ireland, Maynooth, Co., Kildare, Ireland.

Trends in Biotechnology
|July 14, 2001
PubMed

Insights

Developing new mucosal vaccines aims to reduce injections for children. These vaccines use novel strategies to improve immune responses, potentially offering a needle-free immunization alternative.

Area of Science:

  • Immunology
  • Vaccinology
  • Biotechnology

Background:

  • Current pediatric immunization schedules involve numerous injections, causing discomfort and compliance issues.
  • Oral or nasal vaccine delivery offers a needle-free alternative, potentially inducing immunity at the infection site.
  • Protein and polysaccharide antigens delivered mucosally often show poor immunogenicity and can induce tolerance.

Purpose of the Study:

  • To discuss the immunological principles for developing effective mucosal vaccines.
  • To review strategies for enhancing immune responses to mucosal vaccine antigens.
  • To explore the use of immunomodulatory molecules and delivery systems for mucosal vaccines.

Main Methods:

  • Review of immunological principles in mucosal vaccine development.
  • Analysis of strategies to enhance antigen immunogenicity via mucosal routes.
  • Evaluation of immunomodulatory molecules and delivery systems for mucosal vaccination.

Main Results:

  • Novel approaches are emerging to improve the immunogenicity of protein and polysaccharide antigens for mucosal delivery.
  • Immunomodulatory molecules and advanced delivery systems show promise in enhancing mucosal immunity.
  • Selective enhancement of protective immune responses at mucosal surfaces is achievable.

Conclusions:

  • Mucosal vaccines offer a promising needle-free alternative to traditional injections.
  • Further research into immunomodulatory molecules and delivery systems is crucial for effective mucosal vaccine design.
  • Developing effective mucosal vaccines can significantly improve pediatric immunization programs.

More Related Videos

Cationic Nanoemulsion-Encapsulated Retinoic Acid as an Adjuvant to Promote OVA-Specific Systemic and Mucosal Responses06:02

Cationic Nanoemulsion-Encapsulated Retinoic Acid as an Adjuvant to Promote OVA-Specific Systemic and Mucosal Responses

Published on: February 23, 2024

Murine Model of Epicutaneously-Induced Immunomodulation09:07

Murine Model of Epicutaneously-Induced Immunomodulation

Published on: June 24, 2025

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Immunological Memory01:23

Immunological Memory

Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature is...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Vaccine Production01:23

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...